Skip Page Header

Home > Dail Eireann debate. Written answer 128 - Medicinal products availability [33480/15].

[Oireachtas] Dail Eireann debate. Written answer 128 - Medicinal products availability [33480/15]. (30 Sep 2015)


128. Deputy Billy Kelleherasked the Minister for Health if medication will be made available to assist a person's (details supplied) medical condition; and if he will make a statement on the matter. [33480/15]

 

Minister of State at the Department of Health (Deputy Aodhán Ó Ríordáin): The Deputy’s question refers to the use of cannabis plants for medical treatment.

Under the Misuse of Drugs Acts, 1977 to 2015 and the Regulations made thereunder, the manufacture, production, preparation, sale, supply, distribution and possession of cannabis is currently unlawful except for the purposes of research. My Department is aware that cannabis for medicinal use has been legalised in some countries and that there have been several studies internationally on the therapeutic effects of cannabinoids for a number of medical issues. Under European and Irish legislation, before a medicine can be placed on the Irish market the manufacturer has to seek an authorisation from the Health Products Regulatory Authority (HPRA) or in the case of certain medicinal products, the European Medicines Agency (EMA). A determination on an application for authorisation of a medicine is based on a rigorous scientific assessment of the application against legal and regulatory requirements.

In July 2014, the Misuse of Drugs Regulations were amended to allow for certain cannabis based medicinal products to be used in Ireland. Subsequently the HPRA granted a marketing authorisation for a cannabis based medicinal product which is indicated for the relief of certain symptoms for people with multiple sclerosis. My Department will continue to keep developments in relation to cannabis based medical products under review.

Repository Staff Only: item control page